Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “100 Metastatic Patients”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Testing effectiveness (Phase 2)Study completedNCT02339532
What this trial is testing

Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status

Who this might be right for
Breast Cancer
UNICANCER 86
Testing effectiveness (Phase 2)Study completedNCT00019214
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02198274
What this trial is testing

Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 25
Not applicableLooking for participantsNCT07542860
What this trial is testing

Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Secondary PreventionCardiovascular Diseases
Peking University First Hospital 5,448
Large-scale testing (Phase 3)Study completedNCT02603432
What this trial is testing

Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

Who this might be right for
Urothelial Cancer
Pfizer 700
Not applicableNot Yet RecruitingNCT07376096
What this trial is testing

Liquid Biopsy in Germ Cell Tumors

Who this might be right for
100 Stage I Patients100 Metastatic Patients
Medical University of Graz 200
Not applicableStudy completedNCT06481397
What this trial is testing

OSCAR I STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
ExThera Medical Corporation 5
Testing effectiveness (Phase 2)Study completedNCT03448731
What this trial is testing

Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA)

Who this might be right for
Skin Toxicity
Fundacion CRIS de Investigación para Vencer el Cáncer 34
Not applicableNot Yet RecruitingNCT06655142
What this trial is testing

OSCAR II STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Colorectal Carcinoma (mCRC)
ExThera Medical Corporation 120
Post-approval studies (Phase 4)Study completedNCT00891813
What this trial is testing

Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

Who this might be right for
Secondary HyperparathyroidismRenal Insufficiency, ChronicParathyroid Hormone+2 more
Abbott 100
Testing effectiveness (Phase 2)Ended earlyNCT00752986
What this trial is testing

ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial

Who this might be right for
Breast Cancer
Genzyme, a Sanofi Company 39
Large-scale testing (Phase 3)Study completedNCT02239120
What this trial is testing

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Who this might be right for
StrokeSecondary Prevention
Boehringer Ingelheim 5,390
Not applicableStudy completedNCT05520138
What this trial is testing

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 5,506
Large-scale testing (Phase 3)Ended earlyNCT02313909
What this trial is testing

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)

Who this might be right for
Stroke
Bayer 7,213
Testing effectiveness (Phase 2)Study completedNCT02013674
What this trial is testing

The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)

Who this might be right for
Chronic Ischemic Left Ventricular DysfunctionMyocardial Infarction
Joshua M Hare 30
Early research (Phase 1)Study completedNCT00633269
What this trial is testing

Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours

Who this might be right for
Neoplasm Metastasis
AstraZeneca 6
Large-scale testing (Phase 3)Study completedNCT00630032
What this trial is testing

Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 762
Testing effectiveness (Phase 2)UnknownNCT05288127
What this trial is testing

Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature

Who this might be right for
HRD 100 Gene Expression HighTriple Negative Breast Cancer
University of Malaya 55